Skip to main content
. 2019 Jan 23;46(3):186–192. doi: 10.1111/1346-8138.14761

Figure 5.

Figure 5

EQ‐5D domains from week 0 through week 76 in the secukinumab 300 mg FI arm. The data was analyzed using observed values without imputation of any missing values. EQ‐5D, EuroQoL 5‐Dimension Health Questionnaire; FI, fixed interval.